dihexa half life pharmacokinetics half-life Drug handling: Introduction In vivo pharmacokinetic data from

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

BPC-157 has a short half-life of approximately 30 minutes and is metabolized by the liver.5 The benefit of BPC-157 for wound healing is thought to be related to its ability to enhance fibroblast activity, stimulate collagen synthesis, and upregulate skeletal muscle protein synthesis

This molecule is more potent at the human GIP receptor (EC 50 : 0.0643 nM) and less potent at the GLP-1 (EC 50 : 0.775 nM) and glucagon (EC 50 : 5.79 nM) receptors [35]

This places it in the same category as many research peptides, available through certain channels but without official sanction for human use

Monedero Cobeta, I., Salmani, B